Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial.

Leukemia - 1 Mar 2011

Stölzel F, Pfirrmann M, Aulitzky W E, Kaufmann M, Bodenstein H, Bornhäuser M, Röllig C, Kramer M, Mohr B, Oelschlägel U, Schmitz N, Soucek S, Thiede C, Ehninger G, Schaich M

Abstract excerpt

Patients with secondary acute myeloid leukemia (sAML) are generally thought to have a poor prognosis. As there are no prognostic risk stratification models for patients with sAML available, the aim of this study was to obtain a scoring system. Prognostic factors influencing overall survival (OS) and event-free survival (EFS) were analyzed in 305 sAML patients treated in the prospective AML96 trial. The obtained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Logistic Models

Share to Neoplasms, Second Primary

Share to Nuclear Proteins

Share to Nucleophosmin

Share to Platelet Count

Source

Identifiers

PMID: 21135859
DOI: 10.1038/leu.2010.279

Genes

EFS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial.PMID 21135859Read ↗

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries.Semantic proximity Read ↗

Development and validation of a prognostic model for adult patients with acute myeloid leukaemia.Semantic proximity Read ↗

Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient databaseSemantic proximity Read ↗

Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.Semantic proximity Read ↗

Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia.Semantic proximity Read ↗

Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia.Semantic proximity Read ↗

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trialSemantic proximity Read ↗

Development and validation of a prognostic scoring model to risk stratify childhood acute myeloid leukaemia.Semantic proximity Read ↗

A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.